期刊
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
卷 31, 期 8, 页码 1422-1428出版社
WILEY
DOI: 10.1111/jgh.13408
关键词
achalasia; laparoscopic Heller myotomy; peroral endoscopic myotomy; POEM
资金
- Olympus Australia
- Pentax Medical
- Cook Medical
- Boston Scientific
- Medtronic
- Gore Medical
- Johnson and Johnson
Achalasia is a primary esophageal motility disorder. It is the absence of peristalsis in the esophageal body and inability of the lower esophageal sphincter to relax, which characterizes this rare condition. Its features typically include dysphagia, regurgitation, chest pain, and weight loss. The ultimate goal in treating achalasia is to relieve the patient's symptoms, improve esophageal emptying, and prevent further dilatation of the esophagus. Current treatment modalities targeted at achalasia include pharmacological therapy, endoscopic therapy, and surgery. This review focuses on the current therapeutic options and explores the role of peroral endoscopic myotomy in the management armamentarium.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据